Opening Bell: Sensex, Nifty to open higher as U.S. court blocks Trump’s tariffs; Bajaj Auto, Suzlon, SAIL, IRCTC, IndusInd Bank, Gensol shares in focus

The Indian share market is seen to be opening higher on Thursday, tracking firm cues from Asian peers and positive trends in the GIFT Nifty futures. At 8:20 AM, the GIFT Nifty index was trading 98.5 points, or 0.40%, higher at 24,836, indicating a gap-up start for the benchmark indices the BSE Sensex and the NSE Nifty.

In the Asia-Pacific region, the equity markets rallied, undermining weak cues from Wall Street, after a U.S. federal court restricted President Donald Trump’s “Liberation Day” tariffs, saying that he exceeded his authority. The court order has injected optimism in the market amid hope that it would ease global trade tensions. The Nikkei 225 index in Japan rallied 1.65%, while South Korea’s Kospi surged 1.7%. Hong Kong’s Hang Seng gained 0.4%, China’s Shanghai Composite jumped 0.7%, while Singapore’s Straits Times dropped marginally by 0.1%. Meanwhile, Australia’s ASX 200 ended 0.34% higher.

In overnight trade, U.S. stocks ended lower as investors digested minutes from the last U.S. Federal Reserve meeting ahead of earnings reports by chipmaker NVIDIA and Salesforce. The S&P 500 closed 0.56% lower, while the Nasdaq Composite declined 0.51%. The Dow Jones Industrial Average closed 0.58% lower.

On Wednesday, the BSE benchmark Sensex closed lower by 239 points, or 0.29%, at 81,312, and the NSE Nifty50 dropped 74 points, or 0.30%, to settle at 24,752. The broader market continued to show resilience amid value buying by investors, with the Nifty Midcap100 ending marginally lower by 0.02%. On the other hand, the Nifty Smallcap100 ended with a 0.33% gain.

On the sectoral front, fast-moving consumer goods (FMCG), auto, metal, pharma, consumer durables, and healthcare indices were among the top laggards. On the other hand, media, PSU banks, financial services, and energy stocks saw some buying activity.

Stocks to watch today

Q4 results: Bajaj Auto, Suzlon Energy, Mazagon Dock Shipbuilders, SJVN, Ola Electric, Samvardhana Motherson International, Ipca Laboratories, Alkem Laboratories, Amara Raja Energy & Mobility, Bajaj Hindusthan Sugar, Campus Activewear, Engineers India, Gujarat Pipavav Port, Sobha, ICRA, KNR Constructions, and Lemon Tree Hotels will release their quarterly earnings today.

IRCTC: The railway-related company saw its net profit jumping by 26% YoY to ₹358 crore in the March quarter of FY25, while revenue rose to ₹1,269 crore from ₹1,152 crore a year earlier.

IndusInd Bank: The Securities and Exchange Board of India (Seb) has passed an interim order in the high-profile insider trading case, restricting former IndusInd Bank CEO Sumant Kathpalia, along with four other senior executives, from the securities market.

SAIL: The country's largest steel player reported an 11% year-on-year (YoY) rise in net profit at ₹1,251 crore for the fourth quarter that ended on March 31, 2025.

Cummins: The company posted a 7.2% YoY drop in net profit at ₹521.37 crore for Q4 FY25 as compared to ₹561.52 crore in the year ago period.

Gensol Engineering: The National Company Law Tribunal (NCLT), Ahmedabad bench, has initiated strong measures against the company, its related entities, and promoters following serious allegations of financial misconduct, corporate fraud, and systemic violations of governance norms.

Finolex Cables: The company posted a 13.8% YoY growth in revenue to ₹1,594.6 crore in Q4 FY25, while profit rose by 3% to ₹191.7 crore for the quarter.

Birlasoft: The software company clocked a 4.3% YoY growth in Q4 net profit to ₹122 crore, while revenue declined 3.4% to ₹1,317 crore from the corresponding period last year.

Nuvama Wealth Management: The company posted a 41% YoY rise in profit after tax (PAT) at ₹255 crore for Q4FY25, while revenue for the quarter climbed 29% to ₹771 crore.

Bata India: The shoemaker saw its net profit dropping by 27.7% YoY to ₹46 crore, while revenue was marginally down by 1.2% to ₹788.2 crore during the March quarter of FY25.

Natco Pharma: The drug maker reported a consolidated net profit of ₹406 crore for the quarter ending March 31, 2025, up 5% year-on-year from ₹386.3 crore in the corresponding period last year.

RITES: The company has signed a Memorandum of Understanding (MoU) with Shree Cement to develop rail infrastructure and allied services.

Aurobindo Pharma: Curateq Biologics, a wholly owned subsidiary of the company, has incorporated a new wholly owned subsidiary in the Netherlands, named CuraTeQ Biologics B.V.

(DISCLAIMER: The views and opinions expressed by investment experts on fortuneindia.com are either their own or of their organisations, but not necessarily that of fortuneindia.com and its editorial team. Readers are advised to consult certified experts before taking investment decisions.)